Capricor Therapeutics, Inc.
CAPR
$6.97
$0.081.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -81.57% | -16.64% | 4.38% | 16.07% | 23.20% |
| Total Depreciation and Amortization | 33.33% | 42.42% | 56.43% | 74.47% | 100.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.31% | 38.70% | 47.40% | 47.97% | 58.43% |
| Change in Net Operating Assets | 8.23% | -2,029.43% | -458.44% | -313.35% | -140.88% |
| Cash from Operations | -56.25% | -76.01% | -90.76% | -108.28% | -620.62% |
| Capital Expenditure | 24.84% | 39.65% | 29.99% | 29.14% | 39.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,702.15% | -84.62% | 26.78% | 103.12% | 122.56% |
| Cash from Investing | -2,374.46% | -91.71% | 67.30% | 96.86% | 114.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 497.23% | 1,668.75% | 295.05% | 474.54% | 424.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 497.23% | 1,668.75% | 295.05% | 474.54% | 424.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.93% | 10,301.52% | 112.98% | 90.80% | 120.14% |